Options Evaluation After FDA Panel Backing For NPS Pharma
NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) may not yet have formal approval for its short bowel syndrome drug called Gattex, but it has at least received a panel back at the ...Read Full Story »








